Coherus BioSciences Inc (NASDAQ:CHRS)
| 13.88 Delayed Data As of 4:00pm ET |  +0.115 / +0.84%Today’s Change | 5.60 Today|||52-Week Range 19.32 | -13.06% Year-to-Date |
Latest CHRS News | Press Releases
| Top 5 2nd Quarter Trades of COURAGE CAPITAL MANAGEMENT LLC Aug 12 / GuruFocus News - Paid Partner Content | Coherus BioSciences (CHRS) Reports Q2 Loss, Tops Revenue Estimates Aug 04 / Zacks.com - Paid Partner Content |
| Coherus BioSciences (CHRS) Q2 2022 Earnings Call Transcript Aug 06 / MotleyFool.com - Paid Partner Content | Wall Street Analysts Predict an 85% Upside in Coherus BioSciences (CHRS): Here's What You Should Know Aug 03 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 13.76 |
| Today’s open | 13.73 |
| Day’s range | 13.34 - 13.96 |
| Volume | 48,134 |
| Average volume (3 months) | 1,075,983 |
| Market cap | $644.9M |
Data as of 4:00pm ET, 08/15/2022
Growth & Valuation
| Earnings growth (last year) | -305.49% |
| Earnings growth (this year) | +16.00% |
| Earnings growth (next 5 years) | +92.47% |
| Revenue growth (last year) | -31.37% |
| P/E ratio | NM |
| Price/Sales | 3.69 |
| Price/Book | 6.53 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ALECAlector Inc | -0.34 | -2.58% |
| BNGOBionano Genomics Inc | -0.01 | -0.28% |
| DCPHDeciphera Pharmaceut... | +0.23 | +1.40% |
| RYTMRhythm Pharmaceutica... | +4.60 | +21.10% |
Data as of 3:59pm ET, 08/15/2022
Financials
| Next reporting date | November 7, 2022 |
| EPS forecast (this quarter) | -$0.71 |
| Annual revenue (last year) | $326.6M |
| Annual profit (last year) | -$287.1M |
| Net profit margin | -87.92% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Redwood City, California |
Forecasts
